Best Buy To Offer Continuous Glucose Monitoring Systems, Marking Debut Of Prescription Based Medical Devices Sale

Specialty consumer electronics retailer Best Buy Co Inc BBY will soon sell the Dexcom G7 Continuous Glucose Monitoring System (CGM) to eligible customers through BestBuy.com.

This marks the first time Best Buy will offer prescription-based medical devices.

The sale will be facilitated by Wheel, a virtual care platform focused on delivering consumer-centric care and HealthDyne, a pharmacy technology provider.

With the demand for CGM growing over the past few years, using devices like Dexcom G7, means no fingersticks, real-time glucose monitoring and the ability to make smarter decisions about controlling diabetes.

According to the Centers for Disease Control and Prevention (CDC) report, more than 10% of the U.S. population has diabetes. 

The move aligns with the goal of Best Buy Health to facilitate care at home for everyone by relying on partners.

Price Action: BBY shares closed higher by 1.67% at $68.76 on Friday.